drugset
drugset / Trial / NCT07132437

Phase I Clinical Study of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defect

NCT07132437 ↗

Phase 1 Completed 3 enrolled Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
NaSingle-groupOpen-labelOther

Summary

One dose group of 0.004% was used.

Timeline

Start
2021-12-29
Primary completion
2022-05-17
Completion
2022-05-17

Drugs

EvaluationDrugModalityDoseRoute
Subject ZKY001 EYE DROPS Unknown 0.004 % Topical

Indications

corneal disorder